Opendata, web and dolomites

DERMAE

Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DERMAE project word cloud

Explore the words cloud of the DERMAE project. It provides you a very rough idea of what is the project "DERMAE" about.

patients    producing    slices    tool    diagnosis    freeze    announcement    dermatological    potentially    deep    incurs    visually    pathologies    treatment    lesion    entire    mainly    time    scarring    15    instrument    microscope    misses    constitute    healthcare    days    reception    mm    criteria    invasive    12    deformation    biopsies    melanoma    world    solves    tissue    dangerous    excise    dermae    implies    damages    pain    40    60    macroscopic    necessitate    innovative    micrometers    internal    color    biological    tumor    dermatologist    diagnostic    skin    portion    millions    few    reoperation    painful    dermatology    cancers    procedure    excision    diagnoses    consuming    optical    awarded    minor    imaging    tissues    sections    technique    images    structures    patient    consult    diseases    anomaly    surgical    dyes    introduce    size    symptoms    medical    detected    perform    thickness    image    revolutionize    cellular    issue    act    surface    cut    form    situ    histopathological    stress    remove    extra    mu    performed    benign    structural    biopsy    histological    dermatologists    resolution   

Project "DERMAE" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://damaemedical.fr/w/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-04-01   to  2015-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 50˙000.00

Map

 Project objective

Diagnosis and study of many diseases in dermatology, including cancers, mainly depend on biopsy and histopathological analysis of tissue at the cellular-level using an optical microscope. This medical procedure implies to perform a biopsy, i.e. to excise a portion of tissue, then to freeze and cut the sample into slices of a few micrometers thickness and use specific dyes. This procedure is painful and potentially dangerous for the patient. Moreover it is time-consuming and may introduce structural deformation or damages. Skin diseases like Melanoma are rapidly growing throughout the world. About 12 millions biopsies are performed each year by dermatologists. As a minor surgical act, the biopsy process involves pain, possible scarring, and stress during the 15 days before reception of analyses results. In 60% of the cases, the skin anomaly is benign and do not necessitate further treatment. However, the patients need to consult another time with the dermatologist for the announcement of the results of the biopsy, which incurs extra medical costs and time. Moreover, as symptoms are detected on a macroscopic-level with surface criteria (color, form and size of the lesion), the dermatologist misses over one third of the pathologies. Finally, as the tissue excision is visually performed, 40% of reoperation is necessary to remove the entire tumor. DERMAE is a highly recognized and awarded innovative project that solves this major healthcare issue by developing an innovative instrument capable of producing in situ images of biological tissues similar to histological sections. This non- invasive imaging technique will be able to image in real time the internal structures (up to 1 mm deep) of biological tissues at the cellular level (about 1 μm resolution). This imaging technology will constitute a new diagnostic tool that may revolutionize the medical procedures in dermatological diagnoses.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DERMAE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DERMAE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More